Medications Development for Cannabis-Related Disorders (R01)
Application Due Date: | Post Date: 2009-09-24 | Funding Number: RFA-DA-10-016
| Interested in this funding opportunity? Sign Up for it! | CLICK HERE TO SIGNUP -> Expand |
Link to Full Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-10-016.html
Description: Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to issue a Request for Applications (RFA) to support research studies that focus on the identification, and preclinical and clinical evaluation, of medications that can be safe and effective for the treatment of cannabis-use and -induced disorders, as well as their medical and psychiatric consequences. The studies can be preclinical or FDA-defined Phase I, Phase II or Phase III clinical trials. Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with two FOAs of identical scientific scope, PA-07-365 and PA-07-366, that solicit applications under the R01 and R21 mechanisms, respectively. Funds Available and Anticipated Number of Awards. It is anticipated that a total of 6 awards will be funded for a total of $3,000,000.
Estimated Total Program Funding: 3000000
Award Ceiling: 500000
Award Floor: None
Cost Sharing or Matching Requirement: N
CFDA Number: 93.279
Funding Instrument Type: G
Eligible Applicants:
State Governments
County Governments
City or Township Governments
Special district Governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally r
Nonprofits having a 501(c)(3) status with the IRS, other tha
Nonprofits that do not have a 501(c)(3) status with the IRS,
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others